Clinical Trial Update: A Study of 68Ga-PSMA-11 PET Scans in People With Brain Tumors [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial studying Gallium-68 PSMA-11 PET imaging for patients with brain tumors, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• High-grade Glioma

Drugs mentioned

• 68Ga-PSMA-11 (Gallium-68 labeled PSMA-11 radiopharmaceutical)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: High-grade Glioma, Brain Metastases | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING